Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 3
2014 1
2015 3
2016 3
2017 4
2018 4
2019 7
2020 5
2021 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
The multicenter real-world report of the efficacies of 14-day esomeprazole-based and rabeprazole-based high-dose dual therapy in first-line Helicobacter pylori eradication in Taiwan.
Tai WC, Wu IT, Wang HM, Huang PY, Yao CC, Wu CK, Yang SC, Liang CM, Hsu PI, Chuah SK. Tai WC, et al. Among authors: yang sc. J Microbiol Immunol Infect. 2024 Mar 4:S1684-1182(24)00046-X. doi: 10.1016/j.jmii.2024.02.009. Online ahead of print. J Microbiol Immunol Infect. 2024. PMID: 38461114 Free article.
The Efficacy and Safety of 14-day Rabeprazole Plus Amoxicillin High Dose Dual Therapy by Comparing to 14-day Rabeprazole-Containing Hybrid Therapy for the Naïve Helicobacter pylori Infection in Taiwan: A Randomized Controlled Trial.
Tai WC, Yang SC, Yao CC, Wu CK, Liu AC, Lee CH, Kuo YH, Chuah SK, Liang CM. Tai WC, et al. Among authors: yang sc. Infect Dis Ther. 2023 May;12(5):1415-1427. doi: 10.1007/s40121-023-00811-3. Epub 2023 May 3. Infect Dis Ther. 2023. PMID: 37133673 Free PMC article.
Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice.
Hung KT, Yang SC, Wu CK, Wang HM, Yao CC, Liang CM, Tai WC, Wu KL, Kuo YH, Lee CH, Chuah SK. Hung KT, et al. Among authors: yang sc. Infect Drug Resist. 2021 Mar 25;14:1239-1246. doi: 10.2147/IDR.S304711. eCollection 2021. Infect Drug Resist. 2021. PMID: 33790594 Free PMC article.
The efficacies of non-bismuth containing quadruple therapies in the treatment of first-line anti-Helicobacter pylori across 4-year time interval with changing antibiotics resistance.
Huang TH, Yang SC, Tai WC, Liang CM, Kuo CM, Yao CC, Wu CK, Kuo YH, Chou YP, Lee CH, Wu KL, Chuah SK. Huang TH, et al. Among authors: yang sc. Biomed J. 2021 Dec;44(6 Suppl 2):S275-S281. doi: 10.1016/j.bj.2020.11.012. Epub 2020 Nov 24. Biomed J. 2021. PMID: 35292265 Free PMC article.
35 results